eIF4EBP1 抗体
(Eukaryotic Translation Initiation Factor 4E Binding Protein 1 (EIF4EBP1))
This gene encodes one member of a family of translation repressor proteins. The protein directly interacts with eukaryotic translation initiation factor 4E (eIF4E), which is a limiting component of the multisubunit complex that recruits 40S ribosomal subunits to the 5' end of mRNAs. Interaction of this protein with eIF4E inhibits complex assembly and represses translation. This protein is phosphorylated in response to various signals including UV irradiation and insulin signaling, resulting in its dissociation from eIF4E and activation of mRNA translation. [provided by RefSeq, Jul 2008].
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| eIF4EBP1 抗体 (AA 1-118) | 人 | 小鼠 Monoclonal |
|
|
|
| eIF4EBP1 抗体 | 人, 小鼠, 大鼠, 绵羊 | 兔 Polyclonal |
|
|
|
| eIF4EBP1 抗体 (pThr46) | 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| eIF4EBP1 抗体 (pThr37) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| eIF4EBP1 抗体 (pThr46) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| eIF4EBP1 抗体 (pThr69) | 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| eIF4EBP1 抗体 (N-Term) | 人 | 兔 Polyclonal |
|
|
|
| eIF4EBP1 抗体 (Thr36) | 人 | 兔 Polyclonal |
|
|
|
| eIF4EBP1 抗体 (Thr45) | 人 | 兔 Polyclonal |
|
|
|
| eIF4EBP1 抗体 (Ser33) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| eIF4EBP1 抗体 (Ser33) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| eIF4EBP1 抗体 (pSer801) | 人, 小鼠 | 兔 Polyclonal |
|
|
|
| eIF4EBP1 抗体 (pSer64) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| eIF4EBP1 抗体 (Asn63) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| eIF4EBP1 抗体 (Leu58) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| eIF4EBP1 抗体 (Pro30) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| eIF4EBP1 抗体 (Gly39) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| eIF4EBP1 抗体 (pSer65) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| eIF4EBP1 抗体 (Biotin) | 人 | 兔 Polyclonal |
|
|
|
| eIF4EBP1 抗体 (Biotin) | 小鼠 | 兔 Polyclonal |
|
|
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 6C4
- 标记
- unconjugated
- 抗体亚型
- IgG2b
- 抗原表位
- AA 1-118
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 人, 小鼠, 大鼠, 绵羊
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- pThr46
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- pThr37
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- pThr46
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- pThr69
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- N-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- Thr36
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- Thr45
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- Ser33
Primary Antibody
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- Ser33
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 人, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- pSer801
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- pSer64
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- Asn63
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- Leu58
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- Pro30
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- Gly39
Primary Antibody
- ELISA (ELISA: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- pSer65
Primary Antibody
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Biotin
- 抗体亚型
- IgG
Primary Antibody
- WB (Western Blotting: 所列应用)
- 适用
- 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Biotin
- 抗体亚型
- IgG
Latest Publications for our eIF4EBP1 抗体
: "20(s)-Protopanaxadiol (PPD) increases the radiotherapy sensitivity of laryngeal carcinoma." in: Food & function, Vol. 8, Issue 12, pp. 4469-4477, (2018) (PubMed).
: "miR-29b contributes to multiple types of muscle atrophy." in: Nature communications, Vol. 8, pp. 15201, (2018) (PubMed).
: "Downregulation of MCL-1 and upregulation of PUMA using mTOR inhibitors enhance antitumor efficacy of BH3 mimetics in triple-negative breast cancer." in: Cell death & disease, Vol. 9, Issue 2, pp. 137, (2018) (PubMed).
: "Combination of Endothelial-Monocyte-Activating Polypeptide-II with Temozolomide Suppress Malignant Biological Behaviors of Human Glioblastoma Stem Cells via miR-590-3p/MACC1 Inhibiting PI3K/AKT/mTOR ..." in: Frontiers in molecular neuroscience, Vol. 10, pp. 68, (2017) (PubMed).
: "iTRAQ-based comparative proteomic analysis of Vero cells infected with virulent and CV777 vaccine strain-like strains of porcine epidemic diarrhea virus." in: Journal of proteomics, Vol. 130, pp. 65-75, (2016) (PubMed).
: "Association of maternal mRNA and phosphorylated EIF4EBP1 variants with the spindle in mouse oocytes: localized translational control supporting female meiosis in mammals." in: Genetics, Vol. 195, Issue 2, pp. 349-58, (2014) (PubMed).
: "Distinct autoantibody profiles in systemic lupus erythematosus patients are selectively associated with TLR7 and TLR9 upregulation." in: Journal of clinical immunology, Vol. 33, Issue 5, pp. 954-64, (2013) (PubMed).
: "Targeting p53 via JNK pathway: a novel role of RITA for apoptotic signaling in multiple myeloma." in: PLoS ONE, Vol. 7, Issue 1, pp. e30215, (2012) (PubMed).
: "Delayed recovery of skeletal muscle mass following hindlimb immobilization in mTOR heterozygous mice." in: PLoS ONE, Vol. 7, Issue 6, pp. e38910, (2012) (PubMed).
: "Site-specific cleavage of the host poly(A) binding protein by the encephalomyocarditis virus 3C proteinase stimulates viral replication." in: Journal of virology, Vol. 86, Issue 19, pp. 10686-94, (2012) (PubMed).
: "miR-29b contributes to multiple types of muscle atrophy." in: Nature communications, Vol. 8, pp. 15201, (2018) (PubMed).
: "Downregulation of MCL-1 and upregulation of PUMA using mTOR inhibitors enhance antitumor efficacy of BH3 mimetics in triple-negative breast cancer." in: Cell death & disease, Vol. 9, Issue 2, pp. 137, (2018) (PubMed).
: "Combination of Endothelial-Monocyte-Activating Polypeptide-II with Temozolomide Suppress Malignant Biological Behaviors of Human Glioblastoma Stem Cells via miR-590-3p/MACC1 Inhibiting PI3K/AKT/mTOR ..." in: Frontiers in molecular neuroscience, Vol. 10, pp. 68, (2017) (PubMed).
: "iTRAQ-based comparative proteomic analysis of Vero cells infected with virulent and CV777 vaccine strain-like strains of porcine epidemic diarrhea virus." in: Journal of proteomics, Vol. 130, pp. 65-75, (2016) (PubMed).
: "Association of maternal mRNA and phosphorylated EIF4EBP1 variants with the spindle in mouse oocytes: localized translational control supporting female meiosis in mammals." in: Genetics, Vol. 195, Issue 2, pp. 349-58, (2014) (PubMed).
: "Distinct autoantibody profiles in systemic lupus erythematosus patients are selectively associated with TLR7 and TLR9 upregulation." in: Journal of clinical immunology, Vol. 33, Issue 5, pp. 954-64, (2013) (PubMed).
: "Targeting p53 via JNK pathway: a novel role of RITA for apoptotic signaling in multiple myeloma." in: PLoS ONE, Vol. 7, Issue 1, pp. e30215, (2012) (PubMed).
: "Delayed recovery of skeletal muscle mass following hindlimb immobilization in mTOR heterozygous mice." in: PLoS ONE, Vol. 7, Issue 6, pp. e38910, (2012) (PubMed).
: "Site-specific cleavage of the host poly(A) binding protein by the encephalomyocarditis virus 3C proteinase stimulates viral replication." in: Journal of virology, Vol. 86, Issue 19, pp. 10686-94, (2012) (PubMed).
Aliases for eIF4EBP1 抗体
eukaryotic translation initiation factor 4E binding protein 1 (EIF4EBP1) 抗体eukaryotic translation initiation factor 4E binding protein 1 (Eif4ebp1) 抗体
CG8846 gene product from transcript CG8846-RA (Thor) 抗体
eukaryotic translation initiation factor 4E binding protein 1 (eif4ebp1) 抗体
4E-BP 抗体
4e-bp 抗体
4E-BP1 抗体
4e-bp1 抗体
4EBP 抗体
4eBP 抗体
4ebp 抗体
4EBP1 抗体
43-BP 抗体
153432_at 抗体
AA959816 抗体
anon-WO0172774.158 抗体
BcDNA.HL08053 抗体
BcDNA:HL08053 抗体
BP-1 抗体
CG8846 抗体
CT8705 抗体
d4E-BP 抗体
d4e-bp 抗体
d4E-BP1 抗体
d4EBP 抗体
d4eBP 抗体
Dm 4E-BP 抗体
Dmel\\CG8846 抗体
dthor 抗体
eIF4E-BP 抗体
EIF4EBP1 抗体
fc04h09 抗体
l(2)06270 抗体
l(2)k07736 抗体
l(2)k13517 抗体
PHAS-I 抗体
Phas1 抗体
pp20 抗体
thor 抗体
Thor/EIF4EBP 抗体
wu:fc04h09 抗体
zgc:64137 抗体
您还需要查找其他产品吗？
You are here:
